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Abstract
The use of the medicinal leech (Hirudo medicinalis) in promoting venous drainage in tissues whose vitality is threatened by venous
congestion and obstruction, especially in plastic and reconstructive surgery, has been complicated by infections caused by Aeromonas spp.
These are leech endosymbionts for which patients undergoing hirudotherapy frequently receive systemic chemoprophylaxis. In order to
evaluate the possibility of rendering leeches safe for use on patients, H. medicinalis were fed artiﬁcially with a 2 g/L arginine solution (used
as a phagostimulant) supplemented with ciproﬂoxacin (100 mg/L). Aeromonads were detected in 57 out of 80 control leeches (71.3%),
but in none of the 56 leeches treated with ciproﬂoxacin (p <0.001). Treated leeches survived for up to 4 months. Tested weekly, 61% of
these leeches took human blood for at least 4 weeks after treatment and all remained negative for aeromonads. All water samples in
which leeches were kept before treatment were contaminated with Aeromonas spp.; none were detected in any of the NaCl/arginine solu-
tions with which treated animals were fed. Molecular characterization of two phenotypically distinct isolates using gyrB sequencing showed
that one clustered tightly with A. veronii and the other was closely related to A. media. Other environmental bacteria and fungi were iso-
lated from 26.5% of treated leeches that had taken a blood meal 1–4 weeks after treatment. Ciproﬂoxacin reduced the number of leech-
associated aeromonads to undetectable levels for extended periods. Most treated leeches were ready to take a blood meal after treat-
ment, suggesting the possibility of using ciproﬂoxacin-treated leeches instead of chemoprophylaxis in patients undergoing hirudotherapy.
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Introduction
The use of the medicinal leech (Hirudo medicinalis) for the
treatment of human diseases has been known since ancient
Egyptian times. Galen (130–201 AD) used leeches for blood-
letting, which was based on the belief that removal of the
patient’s blood would correct the humoral imbalance and
restore good health [1]. In the 18th and 19th centuries, the
popularity of leeching reached its height in Europe. In 1884,
Haycraft discovered hirudin, an anti-coagulant substance in
leech saliva. Markwardt [2] isolated and characterized this mol-
ecule and in 1986 it was produced by genetic engineering [3].
In recent years, recognition of a number of antithrom-
botic substances and a vasodilator in the saliva of the
medicinal leech [4,5] has generated renewed interest in
the use of the leech itself to promote venous drainage in
tissues whose vitality is threatened by venous congestion
and obstruction, especially after plastic and reconstructive
surgery. In 2004, this treatment modality received the
approval of the Food and Drug Administration in the
USA.
Hirudotherapy, as it is termed, has been complicated by
infections caused by Aeromonas spp. which are considered to
be obligatory endosymbionts of the leech [4]. Infections with
aeromonads have been observed in 7–20% of patients trea-
ted with leeches after reconstructive surgery; in these cases
the chances of successful re-implantation or ﬂap survival
dropped by 30%. Therefore, antibiotics such as cephalospo-
rins or ﬂuoroquinolones are given prophylactically for the
duration of the treatment [1,6].
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In order to reduce the risk of infection, attempts have been
made to remove or decrease the number of aeromonads
inside and outside leeches, by frequent changes of the water
in leech containers, and by submerging leeches in hypochloric
acid and antibiotics, however, these treatment modalities
were not sufﬁcient to destroy the internal bacterial ﬂora of
the leech [7,8]. Antimicrobial prophylaxis for bacteria remain-
ing in the digestive tract is thus necessary to make the
leeches suitable for the treatment of patients, preventing
their internal bacteria from constituting a source of infection.
The purpose of this study was to attempt to suppress the
endosymbiotic aeromonads by feeding leeches artiﬁcially with
a blood-free antibiotic solution, with the ultimate aim of
eliminating the need for chemoprophylaxis in the patients.
Ciproﬂoxacin, which is an agent of choice in the therapy and
prophylaxis of infection as a result of these organisms, was
chosen after preliminary testing showed leech-associated
Aeromonas spp. to be fully susceptible.
Materials and Methods
Leeches
Leeches (Hirudo medicinalis) collected in the wild in Turkey
(Ergene Ltd, Tekirdag) were kept in holding vessels
(40 · 60 · 40-cm plastic containers) in chlorine-free tap
water that was changed weekly. (The authors are familiar
with recent changes in the taxonomy of Hirudo species in
which many medicinally applied leeches have been shown to
be H. verbana rather than H. medicinalis. As the leeches used
in this study were not formally identiﬁed, the latter term
was kept for convenience [9]).
Artiﬁcial feeding
The artiﬁcial feeding device comprised a glass feeding cham-
ber resembling an inverted thistle funnel with a jacket added
for temperature control (Fig. 1). The chamber was pre-
warmed to 38–40C by running warm water through its
outer jacket. This apparatus was inserted into a 250-mL plas-
tic container, to which 100 mL of dechlorinated water had
been added, through a close-ﬁtting hole cut into its lid.
A Paraﬁlm membrane (American National Can, Chicago, IL,
USA) was stretched tightly across the lower part of the
inverted funnel. The feeding solution was added through the
tube of the funnel. This was a 2 g/L arginine solution in
6.4 g/L NaCl, which is a known phagostimulant for leeches
[10,11]. For the decontamination experiments the same solu-
tion was supplemented with 100 mg/L ciproﬂoxacin. Out-
dated transfusion units of human blood replaced the artiﬁcial
phagostimulant to assess the readiness of leeches to take a
blood meal after treatment. After feeding, leeches were
maintained individually in sterilized chlorine-free tap water
containing ciproﬂoxacin at a concentration of 20 mg/L and
examined periodically for bacterial contamination.
Bacteriological examination
Samples were taken from the water in the holding vessels,
from the exterior surface of the animals as well as from their
alimentary tract and from the feeding solution. Leeches were
disinfected externally by immersion in 70% ethyl alcohol for
1 min, followed by transfer to sterile distilled water. The
purpose of this was to ensure that external contaminants did
not interfere with cultures from the intestinal tract.
In order to prevent the entry of alcohol to the digestive
tract and to avoid the discharge of gut contents through the
mouth or anus, a ligature was applied to the proximal and
distal ends (c. 2–3 mm) of the leech. Swabs were taken from
the outer surface of the animals, which were then transected
c. 10 mm distal to the anterior sucker, and crop ﬂuid was
collected using a 10-lL disposable bacteriological loop
(Quadloop; Miniplast, Ein Shemer, Israel) inserted into the
crop. A second incision about 2 mm proximal to the poster-
ior sucker was made and the intestinal contents were sam-
pled with a loop. Samples were inoculated on 5% sheep
blood agar, incubated at 37C and examined after 24 and
48 h. Oxidase positive organisms that grew on MacConkey
agar and fermented glucose were identiﬁed using API 20NE
panels (bioMerieux, Marcy-l’Etoile, France).
Molecular identiﬁcation of Aeromonas species
DNA was extracted using a commercial kit (Wizard Genomic
DNA Puriﬁcation Kit; Promega, Inc., Madison, WI, USA).











FIG. 1. Schematic representation of the artiﬁcial feeding chamber
for leeches.
564 Clinical Microbiology and Infection, Volume 16 Number 6, June 2010 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 563–567
gyrB3F and gyrB14R as described [12]. The 1100-bp amplicons
were puriﬁed and sequenced by a commercial laboratory
(HyLabs, Rehovot, Israel). The resulting gyrB sequences were
then aligned using the ClustalW algorithm to a series of 21
known sequences from 17 different previously characterized
Aeromonas species using MEGA software version 4 (http://
www.megasoftware.net/). A radial phylogenetic tree was con-
structed with the neighbour-joining method, using sequence
data for reference strains of Aeromonas spp. derived from two
studies [12,13] in which the same primers were used.
Statistical methods
Fisher’s exact test was used to compare treated with control
leeches.
Results
Approximately 80% of the leeches engorged fully when fed
artiﬁcially either on human blood or on the arginine/NaCl
solution with and without antibiotics. In 94.4% of the 106
unfed leeches treated with 70% ethyl alcohol no bacteria
were grown from exterior surface samples. However, this
treatment caused the death of the leeches as expected. Aero-
monas spp. were detected in 57 out of 80 control leeches
fed only with arginine/NaCl solution (71.3%), but in none of
the 56 leeches treated with ciproﬂoxacin (p <0.001 using
Fisher’s exact test). In the untreated control leeches, bacte-
ria were found in the intestine, but not in the crop, in 35
animals (61.4%); they were conﬁned to the crop in nine ani-
mals (15.8%), whereas in 13 (22.8%) they were present both
in the crop and intestine.
A blood-meal, through artiﬁcial feeding, was offered to 56
leeches treated with antibiotics. Thirty-four of them took a
blood meal 1–4 weeks after treatment, whereas 22 leeches
refused to feed, all of them in the ﬁrst 2 weeks. All 56
leeches were dissected and examined for Aeromonas spp. All
were negative (Table 1). Aeromonads were also not
detected in the water in which the leeches were kept during
the experimental period.
Ten antibiotic-treated leeches were maintained individually
in sterilized chlorine-free tap water containing ciproﬂoxacin
at a concentration of 20 mg/L. Three died after 2 months,
three after 3 months and four of them survived up to
4 months.
Aeromonads were not detected in any of the 15 arginine/
NaCl samples from feeding chambers that were used to feed
antibiotic-treated leeches, whereas other environmental
microorganisms were found in 16% (9 out of 56) of these
leeches.
Environmental bacteria such as Ochrobactrum spp. and
some ﬁlamentous fungi were also isolated from 26.5% of
treated leeches that had taken a blood meal 1–4 weeks after
treatment (data not shown). All 106 water samples in which
leeches were kept before treatment were contaminated with
Aeromonas spp.
The dominant species was identiﬁed by the API 20NE kit
as A. sobria. Two different phenotypes within this taxon were
studied further: isolates designated 1 and 3. The API 20 NE
proﬁle for isolate 1 was 7176755 (99.2%. T 1.0). Additional
conventional tests showed the isolate to be Voges-Proskauer
positive, DNAse positive and ornithine decarboxylase nega-
tive, all properties consistent with an identiﬁcation of A. vero-
nii biovar sobria [14]. The proﬁle for isolate 3 was 7176744
(84.8%, T 0.72) being much less compatible with the identiﬁ-
cation of A. sobria. This organism was Voges-Proskauer nega-
tive, DNAse negative, ornithine decarboxylase negative and
conﬁrmed negative for citrate, a combination much less con-
sistent with an identiﬁcation of A. veronii biovar sobria.
Clinical diagnostic laboratory methods for identiﬁcation of
Aeromonas spp. are known to be inconclusive [14–16], so
molecular characterization was undertaken to clarify the tax-
onomic status of these isolates. Indeed, the gyrB sequences
revealed that isolate 1 was very closely matched with A. veronii
and that isolate 3 bore most similarity to A. media (Fig. 2).
The API reactions and the additional conventional testing of
this isolate were consistent with this taxon [14].
Discussion
It is generally accepted that the medicinal leech has an oblig-
atory symbiotic relationship with the bacteria of the genus
Aeromonas, which live in its intestinal tract. The symbiotic
bacteria: (i) contribute enzymes such as proteases, lipases
and amylases, which play a major role in digestion; (ii) pro-
vide vitamins of the B-complex, which are sparse in blood;
and (iii) secrete antimicrobial substances, which prevent the
growth of other bacteria and accordingly retard putrefaction
so that the leech can store blood for long periods [4,17].











At 1 week 6 1 0 0
At 2 weeks 31 14 0 2
At 3 weeks 10 10 0 6
At 4 weeks 9 9 0 1
Total 56 34 (61%) 0 9
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In earlier studies, phenotyping of colonizing bacteria classi-
ﬁed all aeromonad isolates from H. medicinalis as A. hydrophila.
As identiﬁcation techniques and classiﬁcation of these organ-
isms evolved, Graf [18] found A. veronii biovar sobria as a single
species in the crop and intestine of this leech. In contrast, Mac-
kay et al. [7] found A. caviae to be the most common species
encountered. Using molecular taxonomic techniques, we iden-
tiﬁed two species among aeromonads colonizing the intestinal
tract of a single population of leeches; A. veronii, phenotypically
consistent with A. veronii var sobria, and A. media.
Recent studies utilizing DNA sequence-based analyses have
thrown new light on the complex biology of the bacterial pop-
ulations of the leech intestine; apart from A. veronii, additional
taxa were identiﬁed, including genera in the a-, c-, and d-Prote-
obacteria, Fusobacteria, Firmicutes, and Bacteroidetes. The
clearly dominant organisms were A. veronii and a novel clone of
a Rikenella-like bacterium of the Bacteroidetes group, designated
PW3, whereas the other clones, considered by the investiga-
tors to represent transient organisms, were typically present
only in low numbers [19–21]. In addition, A. veronii and A. jan-
daei have been cultured from Hirudo orientalis [22], whereas
A. jandaei has been also isolated from Macrobdella decora [23].
In the present study, aeromonads were reduced to levels
undetectable by our methods for up to 4 weeks in all
leeches treated with ciproﬂoxacin and subsequently fed with
human blood. A blood meal is normally followed by prolifer-
ation of aeromonads in the gut. Furthermore these bacteria
were neither found in the water in which the leeches were
kept nor in the blood or arginine solution within the feeding
chamber; the latter observation suggests that aeromonads
were not present in detectable numbers in the mouthparts
or saliva of the leeches.
Several groups have attempted to eliminate the bacterial
load inside and outside leeches by treating them exteriorly
with antibiotics and antiseptics, succeeding only in eliminating
bacteria from the surface of the leech [7,8,18,19].
In this study, the artiﬁcial feeding of leeches was con-
ducted under non-sterile conditions. It is possible that the
bacteria and fungi found in the intestinal tract of the leeches
after antibiotic treatment might have had their origin in the
environment. However, it is equally conceivable that they
were microorganisms that normally exist in very low quanti-
ties in the leech intestine as a result of their sensitivity to
blood components or antimicrobial substances excreted by
the dominant aeromonad, and that ﬂourished after suppres-
sion of the aeromonad by ciproﬂoxacin.
Whitlock et al. [24] predicted that aeromonads would be
an infection risk in hirudotherapy, and Dickson et al. [25]
A. veronii bv. Sobria CECT 4246
A. veronii bv. Veronii CECT 4257
A. veronii bv. Sobria CECT 4906
A. veronii bv. Veronii CECT 4260
Aeromonas 1*
A. culicicola MTCC 3249
A. sobria CECT 4245
A. allosaccharophila CECT 4199
A. hydrophila CECT 839
A. jandaei CECT 4228
A. trota CECT 4255
A. caviae CECT 838
A. caviae CECT 4221
Aeromonas 3*
A. media CECT 4232
A. media CECT 4234
A. eucrenophila CECT 4224
A. encheleia CECT 4342
A. bestiarum CECT 4227
A. popoffii CECT 5176
A. salmonicida sbsp masoucida CECT 896
A. salmonicida sbsp achromogene CECT 895
A. schubertii CECT 4240
0.01
FIG. 2. Phylogenetic position of Aeromo-
nas isolates 1* and 3* according to gyrB
sequences. Phylogenetic tree constructed
with the neighbour-joining method using
sequence data for reference strains of
Aeromonas spp. derived from the studies
of Yanez et al., 2003 [12] and Pidiyar
et al., 2003 [13], in which the same prim-
ers were used. The bar shows 0.01 sub-
stitutions per nucleotide position.
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described a case after breast reconstruction. Since then,
Aeromonas infections after leech application have become
well known, including both soft tissue infections and other
severe infections such as septicaemia and even meningitis
[26–29]. Infections have been observed in 7–20% of patients
treated with leeches, reducing the chances of successful
re-implantations or ﬂaps by 30% [30]. Therefore, during
treatment antibiotics such as cephalosporins or ﬂuoroquinol-
ones are commonly given prophylactically [31].
In the present work, our efforts were directed at detect-
ing an antibiotic effect in treated leeches. It was shown that
either Aeromonas spp. were reduced to undetectable levels in
our system and possibly eliminated, or that surviving bacteria
lost their ability to multiply. As a result of resource limita-
tions at this stage, it was not possible to maximize the sensi-
tivity of detection or to assess whether survivors had
entered a ‘viable but not culturable’ state. The dramatic
reduction in aeromonad densities was a useful endpoint for
the study. It is highly likely that viable but not culturable
organisms might be of no clinical consequence in the clinical
settings in which hirudotherapy is conducted.
In conclusion, the results of the present study suggest that
the strategy of feeding leeches artiﬁcially with antibiotics
reduces the number of aeromonads to undetectable levels
for extended periods, and that treated leeches are likely to
take a blood meal from patients undergoing hirudotherapy.
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